Lantern Pharma Launches National Media Partnership with New to The Street | NewsOut | Nasdaq
Investors + biotech innovators: Lantern Pharma (NASDAQ: LITE) is launching a major national media partnership with New to The Street to spotlight its advancements in AI-driven cancer drug development.
The collaboration includes:
• A full year of national TV interview programming
• Commercial campaigns across top finance channels
• High-impact billboard exposure in NYC’s Financial District and Times Square
Lantern will appear on New to The Street syndicated broadcasts airing on Bloomberg Television and Fox Business Network — part of a broader strategy to engage both institutional investors and the general public through powerful storytelling.
CEO Panna Sharma says the expanded visibility supports Lantern’s mission: accelerate the discovery and development of life-saving oncology therapies using artificial intelligence + data-driven insights.
📍 Reported by Ana Berry for NewsOut.
🔖 Tags
#Investors #Biotech #LanternPharma #Nasdaq #AIinMedicine #CancerResearch #PrecisionOncology #NewToTheStreet #BloombergTV #FoxBusiness #MediaPartnership #TimesSquare #NYSE #NewsOut #AnaBerry #AI #DrugDevelopment #HealthcareInnovation #LifeSciences #BiotechInvesting
